Literature DB >> 2814141

Surgery for cancer of the buccal mucosa.

S A Pradhan1.   

Abstract

Buccal Mucosa cancer is common in India, T4 tumours being the most common (66%). T1 tumours are rarely seen (4%). Disease-free survival (DFS) at 18 mo with surgery alone for T2, T3, and T4 tumours is 57%, 43%, and 21%, respectively. Addition of postoperative radiation therapy (RT) for T3 and T4 lesions increases DFS to 60% and 35%, respectively. Marginal mandibulectomy is advocated for lesions close to the lower gingiva when the bone is clinically and radiologically uninvolved. The local control rate with marginal mandibulectomy is 79%. In T3/T4 tumours, results with supraomohyoid dissection are comparable to radical neck dissection when the upper jugular nodes are histologically negative. In T4 tumours, histological grading forms an important parameter for identification of a favourable subset. In well-differentiated tumours DFS was 48% with surgery and 72% with surgery and postoperative RT; in moderately differentiated tumours it was 12% and 21%, respectively; and in the poorly differentiated group there were no survivors.

Entities:  

Mesh:

Year:  1989        PMID: 2814141     DOI: 10.1002/ssu.2980050505

Source DB:  PubMed          Journal:  Semin Surg Oncol        ISSN: 1098-2388


  7 in total

1.  Clinicopathologic Determinants of Outcome in Pathologic T4a (pT4a) Squamous Cell Carcinoma of the Gingivobuccal Subsite of the Oral Cavity.

Authors:  Prateek V Jain; Rajeev Sharan; Kapila Manikantan; Indranil Mallick; Sanjoy Chatterjee; Indu Arun; Pattatheyil Arun
Journal:  Indian J Surg Oncol       Date:  2019-06-27

2.  Prognostic factors for loco-regional failure in early stage (I and II) squamous cell carcinoma of the gingivobuccal complex.

Authors:  Rohan R Walvekar; Devendra A Chaukar; Mandar S Deshpande; Prathamesh S Pai; Pankaj Chaturvedi; Anagha C Kakade; Anil K D'Cruz
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-01-12       Impact factor: 2.503

3.  What is the way forward for unresectable oral cavity cancers among Indian patients?

Authors:  Santam Chakraborty
Journal:  South Asian J Cancer       Date:  2015 Jan-Mar

4.  Nomogram predicting long-term overall and cancer-specific survival of patients with buccal mucosa cancer.

Authors:  Fengze Wang; Jiao Wen; Shuaishuai Cao; Xinjie Yang; Zihui Yang; Huan Li; Haifeng Meng; Florian M Thieringer; Jianhua Wei
Journal:  BMC Oral Health       Date:  2022-04-22       Impact factor: 2.757

5.  Prognostic factors and related complications/sequalae of squamous cell carcinoma located in the gingivobuccal complex.

Authors:  Yunhao Zhu; Bo Li; Huan Liu; Delong Li; Aoming Cheng; Chong Wang; Zhengxue Han; Zhien Feng
Journal:  World J Surg Oncol       Date:  2022-07-26       Impact factor: 3.253

6.  Induction Chemotherapy in Technically Unresectable Locally Advanced T4a Oral Cavity Squamous Cell Cancers: Experience from a Regional Cancer Center of South India.

Authors:  A H Rudresha; Tamojit Chaudhuri; K C Lakshmaiah; K Govind Babu; Lokanatha Dasappa; Linu Abraham Jacob; M C Suresh Babu; K N Lokesh; L K Rajeev
Journal:  Indian J Med Paediatr Oncol       Date:  2017 Oct-Dec

7.  Clinicopathological Characteristics and Survival Outcomes of Patients with Buccal Squamous Cell Carcinoma: Results of a Multi-Institutional Study.

Authors:  Shogo Shinohara; Masahiro Kikuchi; Hiroyuki Harada; Kiyomi Hamaguchi; Ryo Asato; Hisanobu Tamaki; Masanobu Mizuta; Ryusuke Hori; Tsuyoshi Kojima; Keigo Honda; Takashi Tsujimura; Yohei Kumabe; Kazuyuki Ichimaru; Yoshiharu Kitani; Koji Ushiro; Koichi Omori
Journal:  Medicina (Kaunas)       Date:  2021-12-13       Impact factor: 2.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.